Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

Jasmohan S Bajaj; Douglas M Heuman; James B Wade; Douglas P Gibson; Kia Saeian; Jacob A Wegelin; Muhammad Hafeezullah; Debulon E Bell; Richard K Sterling; R Todd Stravitz

doi:10.1053/j.gastro.2010.08.061

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

Identifier:nobleid.org/w1/20260515/F5AF28DA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F5AF28DA.svg?ark=w1%2F20260515%2FF5AF28DA)](https://nobleid.org/work/w1/20260515/F5AF28DA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy.

Identifier:nobleid.org/w1/20260515/F5AF28DA

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F5AF28DA.svg?ark=w1%2F20260515%2FF5AF28DA)](https://nobleid.org/work/w1/20260515/F5AF28DA)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work